A3 Vertaisarvioitu kirjan tai muun kokoomateoksen osa
Regulatory Aspects of Human Milk Oligosaccharides
Tekijät: Salminen S
Toimittaja: Isolauri E., Sherman P.M., Walker W.A.
Konferenssin vakiintunut nimi: Nestle Nutrition Institute Workshop
Kustantaja: S KARGER AG, MR. THOMAS KARGER, CH-4009 BASEL, SWITZERLAND
Kustannuspaikka: Basel
Julkaisuvuosi: 2017
Kokoomateoksen nimi: Intestinal Microbiome: Functional Aspects in Health and Disease. 88th Nestle Nutrition Institute Workshop, Playa del Carmen, September 2016
Tietokannassa oleva lehden nimi: INTESTINAL MICROBIOME: FUNCTIONAL ASPECTS IN HEALTH AND DISEASE
Lehden akronyymi: NESTLE NUTR WORKS SE
Sarjan nimi: Nestle Nutrition Institute Workshop Series
Vuosikerta: 88
Aloitussivu: 161
Lopetussivu: 170
Sivujen määrä: 10
ISBN: 978-3-318-06030-0
eISBN: 978-3-318-06031-7
ISSN: 1664-2147
DOI: https://doi.org/10.1159/000455400
Human milk oligosaccharides are key components of human milk and appear in various compositions and concentrations in all human milks. In regulatory sense human milk oligosaccharides are classified as novel foods or novel food ingredients requiring safety assessment. In addition, if any health messages are intended to be used also health claim regulations apply. This chapter reviews the regulatory settings and studies human milk oligosaccharides are required to fulfill to be able to enter markets in European Union or United States or elsewhere. Examples include Lacto-N-neotetraose and 2-fucosyllactose with safety assessment in European Union and United States. (C) 2017 Nestec Ltd., Vevey/S. Karger AG, Basel
